Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-intensive AC followed by Abraxane and Herceptin in high-risk breast cancer
NCT00407888Phase 2Completed
- Sponsor
- University of Washington
- Start
- May 2006
- Primary completion
- May 2009
- Modality
- Polymer-based Nanoparticles, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin, cyclophosphamide, nab-paclitaxel, trastuzumab in breast cancer, sponsored by University of Washington. Started May 2006; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00407888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407888.